Hysterectomy Clinical Trials

Clinical trials related to Hysterectomy Procedure

Predictors of Success and Failure of v-NOTES Hysterectomy for Large and Very Large Uteri

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Uterine fibroids are the most common benign tumors in women of reproductive age and are a major indication for hysterectomy. This retrospective, single-center observational study aims to identify factors associated with the success or failure of vaginal natural orifice transluminal endoscopic surgery (v-NOTES) hysterectomy for large and very large uteri. Approximately 50 adult women who underwent v-NOTES hysterectomy for a large uterus at Strasbourg University Hospitals between January 1, 2024, and December 31, 2025, will be included. Data will be extracted retrospectively from medical records. The primary outcome is successful completion of the v-NOTES procedure without conversion to another surgical approach. Potential predictive factors include body mass index, parity, uterine weight, fibroid location, adenomyosis, vaginal access, previous cesarean deliveries or pelvic surgery, and preoperative medical treatments intended to reduce uterine volume or inflammation. Secondary outcomes include surgical complications, operative duration, length of hospital stay, and unplanned readmission within 30 days of surgery.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• Women aged 18 years or older.

• Patients who underwent v-NOTES hysterectomy for a large uterus at Strasbourg University Hospitals between January 1, 2024, and December 31, 2025. The uterine weight threshold for defining a large uterus remains to be determined (280 g or 500 g).

• Patients who have not objected to the reuse of their data for scientific research.

Locations
Other Locations
France
Service de Chirurgie gynécologique - CMCO - Hôpitaux universitaires de Strasbourg - France
RECRUITING
Strasbourg
Contact Information
Primary
Victor Gabriele, MD
victor.gabriele@chru-strasbourg.fr
33 3 69 55 34 55
Time Frame
Start Date: 2026-03-20
Estimated Completion Date: 2027-03-20
Participants
Target number of participants: 50
Sponsors
Leads: University Hospital, Strasbourg, France

This content was sourced from clinicaltrials.gov